Fundz

Unicommerce To Invest Usd 5 Million Towards Expansion In Southeast Asia And Middle East; Targets 400% Growth In Overseas Business

PRIVATENov 23, 2021

Amount Raised

$5 Million

Round Type

Funding Round

Del MarBiotechnologyHealthcareScience And Engineering

Description

Unicommerce, India’s largest e-commerce focused supply chain SaaS platform, has decided to invest USD 5 million to strengthen its international operations and further expand its presence in Southeast Asia and Middle East. The company has been consistently investing and growing its Southeast Asia business and will continue to acquire more clients in these markets. After becoming an undisputed leader in India, Unicommerce aims at establishing itself as a preferred choice of e-tailers and retail brands in the region.

Quick answer

Expansion Therapeutics raised $5 Million in a Funding Round round, dated November 23, 2021. Expansion Therapeutics is based in Del Mar, California, United States.

How much did Expansion Therapeutics raise?
Expansion Therapeutics raised $5 Million in a Funding Round round on November 23, 2021.
What does Expansion Therapeutics do?
Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases including neurodegenerative disorders.
Where is Expansion Therapeutics based and how big is it?
Expansion Therapeutics is based in Del Mar, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Science And Engineering around the same time

Companies in the same sectors as Expansion Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • SPECTRUM PHARMACEUTICALS INC raised an undisclosed amount (Corporate Round) on January 4, 2022.
  • Bond Biosciences raised $6.8M on January 3, 2022.
  • SEELOS THERAPEUTICS, INC. raised $20M (Convertible Note) on November 24, 2021.
  • RedHill Biopharma Ltd raised $5M on November 22, 2021.
  • Athos Therapeutics, Inc. raised an undisclosed amount (Series A) on November 15, 2021.
  • RedHill Biopharma Ltd raised an undisclosed amount (Corporate Round) on November 8, 2021.

Who to call at Expansion Therapeutics, and when

A new round usually means Expansion Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Expansion Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Expansion Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Expansion Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Expansion Therapeutics

Location

Del Mar, California, United States

About

Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases including neurodegenerative disorders. Based on exclusive worldwide rights to groundbreaking research from the laboratory of Matthew D. Disney, Ph.D., at Scripps Research, Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule RNA modulators. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of severe RNA-mediated disease indications. Headquartered in Boston, Massachusetts, Expansion’s research facility is located in Jupiter, Florida. For more information, visit www.expansionrx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Expansion Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Expansion Therapeutics's next move

See what Strategic adds

Expansion Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.